vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and FIRST MID BANCSHARES, INC. (FMBH). Click either name above to swap in a different company.

FIRST MID BANCSHARES, INC. is the larger business by last-quarter revenue ($88.2M vs $77.6M, roughly 1.1× Bioceres Crop Solutions Corp.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs -9.6%, a 36.4% gap on every dollar of revenue. On growth, FIRST MID BANCSHARES, INC. posted the faster year-over-year revenue change (3.4% vs -16.8%). Over the past eight quarters, FIRST MID BANCSHARES, INC.'s revenue compounded faster (5.0% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.

BIOX vs FMBH — Head-to-Head

Bigger by revenue
FMBH
FMBH
1.1× larger
FMBH
$88.2M
$77.6M
BIOX
Growing faster (revenue YoY)
FMBH
FMBH
+20.2% gap
FMBH
3.4%
-16.8%
BIOX
Higher net margin
FMBH
FMBH
36.4% more per $
FMBH
26.8%
-9.6%
BIOX
Faster 2-yr revenue CAGR
FMBH
FMBH
Annualised
FMBH
5.0%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
FMBH
FMBH
Revenue
$77.6M
$88.2M
Net Profit
$-7.4M
$23.7M
Gross Margin
46.8%
Operating Margin
9.3%
34.0%
Net Margin
-9.6%
26.8%
Revenue YoY
-16.8%
3.4%
Net Profit YoY
-20.2%
23.5%
EPS (diluted)
$-0.12
$0.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
FMBH
FMBH
Q4 25
$88.2M
Q3 25
$77.6M
$89.3M
Q2 25
$87.5M
Q1 25
$60.6M
$84.3M
Q4 24
$98.8M
$85.3M
Q3 24
$93.3M
$80.6M
Q2 24
$79.2M
Q1 24
$84.0M
$79.9M
Net Profit
BIOX
BIOX
FMBH
FMBH
Q4 25
$23.7M
Q3 25
$-7.4M
$22.5M
Q2 25
$23.4M
Q1 25
$-1.6M
$22.2M
Q4 24
$605.2K
$19.2M
Q3 24
$-6.2M
$19.5M
Q2 24
$19.7M
Q1 24
$9.8M
$20.5M
Gross Margin
BIOX
BIOX
FMBH
FMBH
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
BIOX
BIOX
FMBH
FMBH
Q4 25
34.0%
Q3 25
9.3%
32.2%
Q2 25
34.4%
Q1 25
1.5%
33.4%
Q4 24
14.5%
29.7%
Q3 24
2.5%
31.5%
Q2 24
33.7%
Q1 24
15.7%
33.7%
Net Margin
BIOX
BIOX
FMBH
FMBH
Q4 25
26.8%
Q3 25
-9.6%
25.2%
Q2 25
26.8%
Q1 25
-2.6%
26.3%
Q4 24
0.6%
22.5%
Q3 24
-6.6%
24.2%
Q2 24
24.9%
Q1 24
11.6%
25.6%
EPS (diluted)
BIOX
BIOX
FMBH
FMBH
Q4 25
$0.98
Q3 25
$-0.12
$0.94
Q2 25
$0.98
Q1 25
$-0.02
$0.93
Q4 24
$0.00
$0.81
Q3 24
$-0.10
$0.81
Q2 24
$0.82
Q1 24
$0.14
$0.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
FMBH
FMBH
Cash + ST InvestmentsLiquidity on hand
$15.5M
Total DebtLower is stronger
$354.5M
Stockholders' EquityBook value
$288.3M
$958.7M
Total Assets
$734.9M
$8.0B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
FMBH
FMBH
Q4 25
Q3 25
$15.5M
Q2 25
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
Q2 24
Q1 24
$16.4M
Total Debt
BIOX
BIOX
FMBH
FMBH
Q4 25
$354.5M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BIOX
BIOX
FMBH
FMBH
Q4 25
$958.7M
Q3 25
$288.3M
$932.2M
Q2 25
$894.1M
Q1 25
$345.0M
$870.9M
Q4 24
$346.3M
$846.4M
Q3 24
$346.0M
$858.5M
Q2 24
$813.6M
Q1 24
$348.5M
$798.0M
Total Assets
BIOX
BIOX
FMBH
FMBH
Q4 25
$8.0B
Q3 25
$734.9M
$7.8B
Q2 25
$7.7B
Q1 25
$798.2M
$7.6B
Q4 24
$835.2M
$7.5B
Q3 24
$827.3M
$7.6B
Q2 24
$7.6B
Q1 24
$836.1M
$7.7B
Debt / Equity
BIOX
BIOX
FMBH
FMBH
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
FMBH
FMBH
Operating Cash FlowLast quarter
$14.4M
$130.9M
Free Cash FlowOCF − Capex
$124.0M
FCF MarginFCF / Revenue
140.6%
Capex IntensityCapex / Revenue
7.8%
Cash ConversionOCF / Net Profit
5.53×
TTM Free Cash FlowTrailing 4 quarters
$207.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
FMBH
FMBH
Q4 25
$130.9M
Q3 25
$14.4M
$33.0M
Q2 25
$7.7M
Q1 25
$23.3M
$47.9M
Q4 24
$-5.4M
$124.4M
Q3 24
$5.2M
$33.1M
Q2 24
$24.0M
Q1 24
$-17.4M
$29.0M
Free Cash Flow
BIOX
BIOX
FMBH
FMBH
Q4 25
$124.0M
Q3 25
$31.9M
Q2 25
$6.0M
Q1 25
$46.0M
Q4 24
$119.5M
Q3 24
$32.0M
Q2 24
$22.9M
Q1 24
$27.6M
FCF Margin
BIOX
BIOX
FMBH
FMBH
Q4 25
140.6%
Q3 25
35.8%
Q2 25
6.8%
Q1 25
54.5%
Q4 24
140.0%
Q3 24
39.7%
Q2 24
28.9%
Q1 24
34.5%
Capex Intensity
BIOX
BIOX
FMBH
FMBH
Q4 25
7.8%
Q3 25
1.2%
Q2 25
2.0%
Q1 25
2.3%
Q4 24
5.8%
Q3 24
1.4%
Q2 24
1.4%
Q1 24
1.9%
Cash Conversion
BIOX
BIOX
FMBH
FMBH
Q4 25
5.53×
Q3 25
1.47×
Q2 25
0.33×
Q1 25
2.16×
Q4 24
-8.85×
6.49×
Q3 24
1.70×
Q2 24
1.21×
Q1 24
-1.78×
1.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons